De waarde van de CRP-sneltest bij exacerbaties van COPD

Rogier Hopstaken a, Sandra Schipper

b

a huisarts Gezondheidscentrum Meerhoven, Eindhoven, tevens Saltro diagnostisch centrum, Utrecht

b student geneeskunde, Universiteit van Maastricht

Referenties

1. Hopstaken RM, Muris JWM, Knottnerus JA, Kester ADM, Rinkens PELM, Dinant GJ. Contributions of

symptoms, signs, erythrocyte sedimentation rate and C-reactive protein to a diagnosis of pneumonia

in acute lower respiratory tract infection. Br J Gen Pract 2003;53:358-64.

2. Cals, JWL, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C-

reactive protein and training in communication skills on antibiotic use in lower respiratory tract

infections: cluster randomised trial. Brit Med J 2009;338:b1374.

3. Verheij ThJM, Hopstaken RM, Prins JM, Salomé PhL, Bindels PJ, Ponsioen BP†, Sachs APE, Thiadens

HA, Verlee E. M78 NHG-Standaard Acuut hoesten (eerste herziening). Huisarts Wet 2011; 54(2):68-

92.

4. Hopstaken R, Verdijk N, Van den Broek N, Verspaandonk K, Meulepas M, Helder C, Keyzer J. CRP-

sneltest in de dagelijkse praktijk. Huisarts Wet 2012;55(9):388-92.

5. Smeele IJM, van Weel C, van Schayck CP, van der Molen T, Schermer T, Sachs APE, Muris JWM,

Chavannes NH, Kolnaar BGM, Grol MH, Geijer RMM. NHG-Standaard COPD. Huisarts Wet

2007;50(8):362-79.

6. Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes NC. Antibiotics for

exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;

CD004403.

7.Puhan MA, Vollenweider D. Respir.Res. 2007 Puhan MA, Vollenweider D, Latshang T, Steurer

J, Steurer-Stey C: Exacerbations of chronic obstructive pulmonary disease: when are antibiotics

indicated? A systematic review. Respiratory research 2007, 8:30.

8. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention

of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;

176(6): 532–555.

9. Weis N , Almdal T . C-reactive protein—can it be used as a marker of infection in patients with

exacerbation of chronic obstructive pulmonary disease? Eur J Intern Med. 2006; 17( 2):88-91.

10. Hopstaken RM, Stobberingh EE, Knottnerus JA, et al. Clinical items not helpful in differentiating

viral from bacterial lower respiratory tract infections in general practice. J Clin Epidemiol 2005;

58:175-83.

11. Antonescu-Turcu AL, Tomic R. C-reactive protein and copeptin: prognostic predictors in chronic

obstructive pulmonary disease exacerbations. Current Opinion in Pulmonary Medicine 2009, 15:120–

125.

12. de Torres JP, Cordoba-Lanus E, Lo´pez-Aguilar C, et al. C-reactive protein levels and clinically

important predictive outcomes in stable COPD patients. Eur Respir J 2006;27: 902–907.

13. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein

as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007

Feb 1;175(3):250e5.

14. Man P, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality

in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849–853.

15.Shabaan R, Kony S, Driss F. et al Change in C-reactive protein levels and FEV1 decline: a

longitudinal population-based study. Respir Med 2006. 1002112–2120.2120.

16. Perera WR , Hurst JR , Wilkinson TM , et al . Inflammatory changes, recovery and recurrence at

COPD exacerbation. Eur Respir J 2007;29(3): 527-534 .